Table 3.
Authors | Year | n | Age, mean (SD) | Male sex, % | Symptom assessment tool | Constipation prevalence, % |
---|---|---|---|---|---|---|
HD | ||||||
Chong and Tan38 | 2013 | 123 | 52 (13) | 47 | Questionnaire | 1.6 |
Salamon et al.42 | 2013 | 172 | 63 (14) | 66 | Interview by dietitian | 23.8 |
Bossola et al.36 | 2011 | 110 | 65 (15) | 64 | Questionnaire | 27.3 |
Ramos et al.43 | 2015 | 50 | 51 (12) | 58 | Rome III questionnaire | 32.8 |
Cano et al.4 | 2007 | 100 | 21–86 (range) | 52 | Locally validated Rome II | 33.0 |
Dong et al.39 | 2014 | 182 | 59 (14) | 59 | Modified GSRS | 36.3 |
Wang et al.44 | 2001 | 20 | 64 (11) | 40 | Self-reporting diaries | 38.0 |
Hammer et al.35 | 1998 | 105 | N/A | N/A | Questionnaire | 40.0 |
Daniels et al.45 | 2015 | 120 | 60 (15) | 47 | GSRS | 52.5 |
Yasuda et al.3 | 2002 | 268 | 56 (2) | 62 | Questionnaire | 63.1 |
Ikee et al.40 | 2016 | 136 | 67 (12) | 68 | Laxative use | 66.2 |
Zhang et al.37 | 2013 | 478 | 53 (14) | 54 | Rome III questionnaire | 71.7 |
PD | ||||||
Zhang et al.37 | 2013 | 127 | 45 (13) | 54 | Rome III questionnaire | 14.2 |
Dong and Guo46 | 2010 | 112 | 60 (14) | 54 | Modified GSRS | 17.9 |
Cano et al.4 | 2007 | 48 | 19–87 (range) | 65 | Locally validated Rome II | 27.0 |
Salamon et al.42 | 2013 | 122 | 61 (14) | 61 | Interview by dietitian | 28.7 |
Yasuda et al.3 | 2002 | 204 | 50 (14) | 63 | Questionnaire | 28.9 |
Mitrovic and Majster47 | 2015 | 72 | N/A | N/A | GSRS | 90.3 |
NDD-CKD | ||||||
Lee et al.48 | 2016 | 21 | 64 (14) | 48 | Rome III questionnaire | 4.8 |
Bristol Stool Scale | 19.0 |
CKD, chronic kidney disease; ESRD, end-stage renal disease; GSRS, Gastrointestinal Symptom Rating Scale; HD, hemodialysis; N/A, not available; NDD, non–dialysis-dependent; PD, peritoneal dialysis.
Modified with permission from Zuvela J, Trimingham C, Le Leu R, et al. Gastrointestinal symptoms in patients receiving dialysis: a systematic review. Nephrology (Carlton). 2018;23:718–727.41